和黄医药(US ADR) (HCM.O)

+ 收藏

资产负债表(和黄医药(US ADR))

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
截止日期 2023-12-312023-06-302022-12-312022-06-30
报表类型 合并报表合并报表合并报表合并报表
报表年结日 1231123112311231
原始币种 美元美元美元美元
上市前/上市后 上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 283,589,000.00222,996,000.00313,278,000.00467,502,000.00
 受限制存款及现金流动(元) ---73,034,000.00
 应收账款及票据(元) 116,894,000.00129,203,000.0097,988,000.0077,078,000.00
 应收关联方款项(元) 28,462,000.0021,959,000.00--
 预付款项及其他应收款流动(元) 14,889,000.0029,280,000.0054,214,000.00-
 存货(元) 50,258,000.0053,875,000.0056,690,000.0045,925,000.00
 短期投资(元) 602,747,000.00633,172,000.00317,718,000.00358,698,000.00
 流动资产合计(元) 1,096,839,000.001,090,485,000.00839,888,000.001,022,237,000.00
非流动资产:
 物业、厂房及设备(元) 99,727,000.0096,829,000.0075,947,000.0044,059,000.00
 预付款项及其他长期应收款非流动(元) -32,896,000.00--
 递延所得税资产非流动(元) 15,456,000.00-15,366,000.00-
 长期投资(元) 48,411,000.0037,740,000.0073,777,000.0082,999,000.00
 非流动资产其他项目(元) 19,340,000.0039,547,000.0024,467,000.0045,038,000.00
 非流动资产合计(元) 182,934,000.00207,012,000.00189,557,000.00172,096,000.00
总资产(元) 1,279,773,000.001,297,497,000.001,029,445,000.001,194,333,000.00
流动负债:
 短期债务及长期负债本期部分(元) 31,155,000.00---
 融资租赁负债流动(元) 3,927,000.00---
 应付账款及票据(元) 36,327,000.0054,575,000.0071,115,000.0051,005,000.00
 应付税项流动(元) 2,580,000.00-1,112,000.00-
 其他应付款及应计费用(元) 271,399,000.00227,212,000.00264,621,000.00233,606,000.00
 递延收入流动(元) 57,639,000.0052,264,000.00--
 流动负债其他项目(元) -6,812,000.0017,055,000.0037,245,000.00
 流动负债合计(元) 403,027,000.00340,863,000.00353,903,000.00321,856,000.00
非流动负债:
 长期债务(元) 48,189,000.0040,147,000.0018,104,000.00418,000.00
 融资租赁负债非流动(元) 2,860,000.00-5,196,000.00-
 递延收入非流动(元) 69,480,000.0097,176,000.00--
 递延所得税负债非流动(元) 1,484,000.00-2,710,000.00-
 非流动负债其他项目(元) 11,346,000.0019,294,000.0012,662,000.0020,210,000.00
 非流动负债合计(元) 133,359,000.00156,617,000.0038,672,000.0020,628,000.00
总负债(元) 536,386,000.00497,480,000.00392,575,000.00342,484,000.00
股东权益:
 普通股(元) 87,126,000.0086,616,000.0086,478,000.0086,457,000.00
 股本溢价(元) 1,522,447,000.001,506,280,000.001,497,273,000.001,484,578,000.00
 留存收益(元) -870,869,000.00-803,057,000.00-971,481,000.00-773,189,000.00
 累计其他全面收益(元) -8,163,000.00-7,800,000.00-1,903,000.001,882,000.00
 归属于母公司股东权益(元) 730,541,000.00782,039,000.00610,367,000.00799,728,000.00
 少数股东权益(元) 12,846,000.0017,978,000.0026,503,000.0052,121,000.00
 股东权益合计(元) 743,387,000.00800,017,000.00636,870,000.00851,849,000.00
负债及股东权益合计(元) 1,279,773,000.001,297,497,000.001,029,445,000.001,194,333,000.00
公告日期 2024-02-282023-07-312023-02-282022-08-01
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院